Instead of requiring personalized gene edits for each patient, the new approach could create a standardized method to use for many diseases. By Pam Belluck and Carl Zimmer Gene-editing therapies offer ...
Urnov is a professor of molecular therapeutics at the University of California, Berkeley, and a director at its Innovative Genomics Institute. In May, news broke of a biomedical first: the on-demand ...
Researchers created a highly efficient gene-editing method that fixes multiple DNA mutations in a single step. The breakthrough could revolutionize genetic medicine by making treatments for complex ...
A major medical milestone took place in May 2025, when doctors at the Children’s Hospital of Philadelphia used CRISPR-based gene editing to treat a child with a rare genetic disorder. Unlike earlier ...
In today’s installment of “hey please don’t do that,” the Wall Street Journal reports that a clandestine startup named Preventive is trying to usher in the first known birth of a genetically-modified ...
Promising results from a small clinical trial highlight a growing interest in designing gene-editing treatments for common illnesses. So far, only 15 people have received the treatment. But, if all ...
Jason Mast is a general assignment reporter at STAT focused on the science behind new medicines and the systems and people that decide whether that science ever reaches patients. You can reach Jason ...
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol and triglycerides in people with difficult-to-treat lipid disorders, ...
IS HOLDING A FUNDRAISER TO HELP TWO OF THEIR CHILDREN. BOTH CHILDREN HAVE A GENETIC DISORDER THAT, AMONG OTHER THINGS, CAUSES A FLOOD OF SEIZURES. AND THE ANSWER TO THE PROBLEM MAY LIE IN A GENE ...
CLEVELAND — Gene editing is the revolution in medical history and a groundbreaking Cleveland Clinic trial is demonstrating how this technology could transform the way millions of Americans manage high ...
When genetics and fertility startup Nucleus Genomics plastered ads across New York City’s subway stations urging riders to ...